Lagerbedingungen Bewahren Sie den Behlter dicht verschlossen an einem trockenen, khlen Ort auf und schtzen Sie ihn vor Sonnenlicht
Visual Signs in Lyophilized Peptide Normal: White to off-white fluffy powder, loosely filling the vial Concern: Powder appears wet, compacted, or stuck to the vial wall suggests moisture ingress Concern: Visible yellow or brown discoloration may indicate oxidative degradation Concern: Vial seal is damaged or stopper appears compromised potential contamination Visual Signs in Reconstituted Peptide Normal: Clear, colorless to very pale yellow solution, free of visible particles Concern: Cloudiness or turbidity suggests aggregation or contamination Concern: Visible particulate matter suggests degradation or contamination Concern: Strong or unusual odor suggests microbial contamination If any of these signs are present, do not use the material
MiR-26a-5p Enhances Cells Proliferation, Invasion, and Apoptosis Resistance of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis by Regulating PTEN/PI3K/AKT Pathway
Pi-Sunyer X
doi: 10.1126/science.aav7062 214 MuellerSNVanguriVKHaSJWestEEKeirMEGlickmanJNet al
Phase 2/3 trial of structurally distinct prodrug fosgonimeton (Athira ATH-1017) missed primary endpoint in 2023 Product Specifications Format: capsules Strength: 10 mg per capsule Count: 30 capsules per bottle Purity: 98% (HPLC verified) Container: sealed amber bottle Certificate of Analysis: lot-specific COA available See the FDA Disclosure, Storage Instructions, and RUO tabs for handling, storage, and regulatory information